US consumers who purchased Neon Obsession pressed pigment palettes may be entitled to refunds under a settlement preliminarily approved in California’s Central District. Plaintiffs say Huda promoted Neon Obsession as eyeshadow despite use of color additives not approved by the FDA for eye-area use, an issue that cannot be cured by a “buried” disclaimer on product packaging.
HB USA Holdings, Inc., dba Huda Beauty, will pay any and all valid claims from customers who purchased its Neon Obsession “multiuse pigment palette” under a class action settlement headed for final approval in California federal court.
According to plaintiffs in the consolidated class action, Huda calls the product in question a multiuse pigment palette, but representations,...
Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.
Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.
Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.
The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”
